Title : CRISPR\/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury - Leuillier_2023_J.Adv.Res_43_163
Author(s) :
Leuillier M , Duflot T , Menoret S , Messaoudi H , Djerada Z , Groussard D , Denis RGP , Chevalier L , Karoui A , Panthu B , Thiebaut PA , Schmitz-Afonso I , Nobis S , Campart C , Henry T , Sautreuil C , Luquet SH , Beseme O , Feliu C , Peyret H , Nicol L , Henry JP , Renet S , Mulder P , Wan D , Tesson L , Heslan JM , Duche A , Jacques S , Ziegler F , Brunel V , Rautureau GJP , Monteil C , do Rego JL , do Rego JC , Afonso C , Hammock B , Madec AM , Pinet F , Richard V , Anegon I , Guignabert C , Morisseau C , Bellien J
Ref :
J Adv Res , 43 :163 , 2023
Abstract :
View Abstract
PubMedSearch : Leuillier_2023_J.Adv.Res_43_163
PubMedID : 36585106
Gene_locus related to this paper:
human-EPHX2